Megan Smeykal - 18 Feb 2026 Form 4 Insider Report for TELA Bio, Inc. (TELA)

Role
Chief Accounting Officer
Signature
/s/ Megan Smeykal
Issuer symbol
TELA
Transactions as of
18 Feb 2026
Net transactions value
-$2,097
Form type
4
Filing time
24 Feb 2026, 20:00:13 UTC
Previous filing
02 Apr 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Smeykal Megan Chief Accounting Officer C/O TELA BIO, INC., 1 GREAT VALLEY PARKWAY, SUITE 24, MALVERN /s/ Megan Smeykal 24 Feb 2026 0001899973

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TELA Common Stock Award $0 +32,850 +89% $0.000000 69,681 18 Feb 2026 Direct F1
transaction TELA Common Stock Tax liability $632 -795 -1.1% $0.7950 68,886 19 Feb 2026 Direct F2
transaction TELA Common Stock Tax liability $1,141 -1,590 -2.3% $0.7174 67,296 21 Feb 2026 Direct F2
transaction TELA Common Stock Tax liability $324 -423 -0.63% $0.7660 66,873 23 Feb 2026 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These restricted stock units ("RSUs") will vest in four equal annual installments beginning on February 18, 2027, subject to the Reporting Person's continuous service through the applicable vesting dates.
F2 Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of RSUs.